emitefur has been researched along with Carcinoma, Epidermoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asakawa, M; Fujii, M; Fukuoka, M; Furuse, K; Nakai, Y; Niitani, H; Ohta, M; Yamaguchi, Y; Yoshida, K | 1 |
| Hirohashi, M; Miyauchi, S; Murata, R; Oya, N; Sasai, K; Shibamoto, Y; Shibata, T; Takagi, T; Takahashi, M | 1 |
| Osaki, T; Ueta, E; Yamamoto, T; Yoneda, K | 1 |
1 trial(s) available for emitefur and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II study.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vomiting | 1994 |
2 other study(ies) available for emitefur and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Tumor Stem Cell Assay | 1996 |
The inhibitory action of BOF-A2, a 5-fluorouracil derivative, on squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; DNA, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Proliferating Cell Nuclear Antigen | 1999 |